Receptor tyrosine kinase-like orphan receptor 1 (ROR1) - a cell signature gene for minimal residual disease (MRD) detection in chronic lymphocytic leukemia (CLL)

被引：0
|
作者：
Uhrmacher, S. [1 ]
Schmidt, C. [1 ]
Filipovich, A. [1 ]
Erdfelder, F. [1 ]
Hallek, M. [1 ]
Kreuzer, K-A [1 ]
机构：
[1] Univ Cologne, Klin Innere Med 1, Cologne, Germany
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [31] Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy
    Shabani, Mahdi
    Naseri, Jila
    Shokri, Fazel
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (07) : 941 - 955
  • [32] Immune therapy for chronic lymphocytic leukemia induces the antibody response against a novel tumor-associated antigen, the orphan tyrosine kinase receptor ROR1
    Fukuda, T
    Rassenti, LZ
    Kipps, TJ
    [J]. BLOOD, 2005, 106 (11) : 834A - 835A
  • [33] Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) Is Expressed in Low Grade NHL and B-CLL and Activates the Non Canonical Wnt Pathway
    Gibellini, Federica
    Chapman, Colby M.
    Herishanu, Yair
    Vire, Berengere
    Keyvanfar, Keyvan
    Njuguna, Ndegwa
    Wiestner, Adrian
    [J]. BLOOD, 2008, 112 (11) : 1284 - 1284
  • [34] ROR1 is an accurate and reliable marker of minimal residual disease in chronic lymphocytic leukaemia
    De Propris, Maria Stefania
    Intoppa, Stefania
    Milani, Maria Laura
    Mariglia, Paola
    Nardacci, Maria Grazia
    Peragine, Nadia
    Foa, Robin
    Guarini, Anna
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (06) : e346 - e349
  • [35] Backbone and side-chain chemical shift assignments of the kringle domain of human receptor tyrosine kinase-like orphan receptor 1 (ROR1) (vol 12, pg 145, 2018)
    Ma, Xiaofang
    Zhang, Yingying
    Liu, Bin
    Yang, Jiahui
    Hu, Kaifeng
    [J]. BIOMOLECULAR NMR ASSIGNMENTS, 2018, 12 (02) : 363 - 363
  • [36] Receptor tyrosine kinase-like orphan receptor 1: A novel antitumor target in gastrointestinal cancers
    Wu, Zheng-Long
    Wang, Ying
    Jia, Xiao-Yuan
    Wang, Yi-Gang
    Wang, Hui
    [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2024, 15 (05):
  • [37] ROR1 Negative Chronic Lymphocytic Leukemia (CLL) Have a Distinctive Gene Expression Signature and May Represent an Indolent-Disease Subtype
    Ghia, Emanuela M.
    Rassenti, Laura Z.
    Chen, Liguang
    Cui, Bing
    Deboever, Christopher
    Frazer, Kelly A.
    Kipps, Thomas J.
    [J]. BLOOD, 2015, 126 (23)
  • [38] Vls-101 Is a Novel Therapeutic Antibody-Drug Conjugate (ADC) Targeting Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) in Richter's Syndrome (RS)
    Vaisitti, Tiziana
    Jessen, Katti
    Vo, Thanh-Trang
    Ko, Mira
    Arruga, Francesca
    Vitale, Nicoletta
    Braggio, Esteban
    Di Napoli, Arianna
    Chadburn, Amy
    Allan, John N.
    Furman, Richard R.
    Miller, Langdon L.
    Lanutti, Brian J.
    Deaglio, Silvia
    [J]. BLOOD, 2019, 134
  • [39] Expression profile of orphan receptor tyrosine kinase (ROR1) and Wilms' tumor gene 1 (WT1) in different subsets of B-cell acute lymphoblastic leukemia
    Shabani, Mahdi
    Asgarian-Omran, Hossein
    Vossough, Parvaneh
    Sharifian, Ramazan A.
    Faranoush, Mohammad
    Ghragozlou, Soheila
    Khoshnoodi, Jalal
    Roohi, Azam
    Jeddi-Tehrani, Mahmood
    Mellstedt, Hakan
    Rabbani, Hodjatallah
    Shokri, Fazel
    [J]. LEUKEMIA & LYMPHOMA, 2008, 49 (07) : 1360 - 1367
  • [40] A new class of anti-cancer drugs targeting the tyrosine kinase receptor ROR1 in CLL
    Mellstedt, Hakan
    Khan, Salam
    Hojjat-Farsangi, Mohammad
    Daneshmanesh, Amir Hossein
    Vagberg, Jan
    Bystrom, Styrbjorn
    Schultz, Johan
    Norin, Martin
    Olsson, Elisabeth
    Lofberg, Charlotte
    Norstrom, Carina
    Olin, Thomas
    Tsterborg, Anders
    Moshfegh, Ali
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345